Eplerenone + Placebo
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
23
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Hypoglycemia
Conditions
Hypoglycemia
Trial Timeline
Jan 1, 2011 → Aug 1, 2016
NCT ID
NCT01394627About Eplerenone + Placebo
Eplerenone + Placebo is a pre-clinical stage product being developed by Johnson & Johnson for Hypoglycemia. The current trial status is completed. This product is registered under clinical trial identifier NCT01394627. Target conditions include Hypoglycemia.
Hype Score Breakdown
Clinical
5
Activity
2
Company
10
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01394627 | Pre-clinical | Completed |
Competing Products
20 competing products in Hypoglycemia